MRVI

MARAVAI LIFESCIENCES HLDGS I

MRVI·56600D107·US·Common Stock·Healthcare - Biotechnology-13D/G

MRVI (MARAVAI LIFESCIENCES HLDGS I) is held by 90 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($26.4M), MACKENZIE FINANCIAL CORP ($17.8M), VANGUARD CAPITAL MANAGEMENT LLC ($15.4M). Net institutional sentiment: Mixed.

90
Holders
Avg rating(20 Elite)
$185.4M
Total Value
59% (97)
Fund Consensus
53 buying - 37 selling
MRVISmart Money Verdict
View all
Held by 90 funds
20 elite
Who's Trading
ActivistMillennium Management LLCMillennium Management LLC4.7%Jun 29, 2026
ActivistMillennium Management LLCMillennium Management LLC5.0%Jun 23, 2026
InsiderOKORESHACK KURTSell $128KJun 10, 2026
InsiderOKORESHACK KURTSell $127KJun 9, 2026
Activist1W12 West Capital Management LP4.9%May 15, 2026
ActivistSFStuart Feldman7.1%May 14, 2026
ActivistMillennium Management LLCMillennium Management LLC4.9%May 12, 2026
InsiderLTLUCIER GREGORY TBuy $178KDec 8, 2025
InsiderLTLUCIER GREGORY TBuy $190KDec 5, 2025
InsiderBBBrust BerndBuy $703KNov 13, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
9.3M(-0.3%)$26.4M0.0%+12.77%
0
Increased
6.3M(+2.1%)$17.8M0.0%-45.44%
29
New
5.4M$15.4M0.0%+65.04%
39
Increased
4.3M(+0.9%)$12.1M0.0%-61.44%
28
Decreased
3.3M(-3.7%)$9.4M0.0%+2.76%
0
Increased
3.2M(+12.6%)$9.1M0.0%+83.85%
31
Decreased
2.8M(-0.7%)$8M0.0%-72.40%
0
Increased
2.5M(+40.3%)$7.1M0.0%+83.88%
36
Increased
2.4M(+0.6%)$6.9M0.0%-8.40%
27
Increased
2.1M(+4.0%)$5.9M0.0%+77.76%
28
Increased
2M(+0.3%)$5.7M0.0%+28.59%
27
Increased
1.8M(+6.0%)$5.1M0.1%+16.44%
29
Decreased
1.6M(-8.2%)$4.7M0.0%+51.92%
0
Increased
1.6M(+26.3%)$4.6M0.0%+90.06%
33
Increased
1.6M(+86.9%)$4.5M0.0%+81.40%
42
Increased
1.5M(+140.4%)$4.2M0.0%+75.78%
43
Increased
1.4M(+64.8%)$4M0.0%-18.41%
39
Increased
1.1M(+26.1%)$3.1M0.0%-60.76%
33
Increased
993,348(+0.5%)$2.8M0.0%-73.20%
26
New
952,838$2.7M0.0%+65.04%
36

Showing 1-20 of 97

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used